文献速递腹部技术与安全US

超声造影用于肝细胞癌诊断——AJR专家小组叙述性综述

Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Diagnosis-AJR Expert Panel Narrative Review.
PubMed 文献 · AJR Am J Roentgenol · 2026-02-04

该AJR专家小组叙述性综述针对超声造影(CEUS)在肝细胞癌(HCC)诊断中临床应用不一致的问题,提供跨人群的实用见解,涵盖高危人群、代谢功能障碍相关脂肪性肝病及非高危人群。文章讨论CEUS诊断标准、鉴别非HCC恶性肿瘤、≤2 cm病灶、B型超声隐匿病灶及CT/MRI不确定病灶,区分纯血池与血池联合Kupffer细胞两类对比剂,并涉及非放射治疗后的疗效评估和人工智能影响,最后给出专家小组共识声明。

要点

  • CEUS可用于高危人群HCC诊断,并鉴别HCC与非HCC恶性肿瘤。
  • CEUS有助于评估≤2 cm病灶、B型超声隐匿病灶及CT/MRI不确定病灶。
  • 肝影像所用超声对比剂分纯血池类与血池联合Kupffer细胞类两种。

核心结论

  • 文章总结专家小组共识声明,强调CEUS在HCC诊断路径中的实用价值,并指出需进一步研究的知识空白。

研究设计与样本

  • AJR专家小组叙述性综述,未报告系统检索范围与纳入文献数量。

临床应用与阅片要点

  • 文章未给出具体临床操作推荐;专家小组共识声明以原文为准。

局限性

  • 原文指出需进一步研究的知识空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Despite growing clinical use of contrast-enhanced ultrasound (CEUS), inconsistency remains in the modality's role in clinical pathways for hepatocellular carcinoma (HCC) diagnosis and management. This AJR Expert Panel Narrative Review provides practical insights on the use of CEUS for the diagnosis of HCC across populations, including individuals at high risk for HCC, individuals with metabolic dysfunction-associated steatotic liver disease, and individuals not at high risk for HCC. Considerations addressed with respect to high-risk patients include CEUS diagnostic criteria for HCC, use of CEUS for differentiating HCC from non-HCC malignancy, use of CEUS for small (≤ 2 cm) lesions, use of CEUS for characterizing occult lesions on B-mode ultrasound, and use of CEUS for indeterminate lesions on CT or MRI. Representative literature addressing the use of CEUS for HCC diagnosis and gaps in knowledge requiring further investigation are highlighted. Throughout these discussions, the article distinguishes two broad types of ultrasound contrast agents used for liver imaging: pure blood-pool agents and a combined blood-pool and Kupffer-cell agent. Additional topics include the use of CEUS for treatment response assessment after nonradiation therapies and implications of artificial intelligence technologies. The article concludes with a series of consensus statements from the author panel.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Li L, Dioguardi Burgio M, Fetzer DT, et al. Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Diagnosis-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2026. PMID: 40434167. doi:10.2214/AJR.25.32813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。